Patentpool Group

Patentpool Group is a Munich-based venture capital firm specializing in managing patentable technologies and early-stage investments. Since its founding in 1998, the firm has been transforming innovations into marketable technologies and products by providing capital, expertise, and a broad network. Their focus spans various sectors, including information technology, technological sciences, medicine, pharmaceuticals, and sustainability technologies.

Unlike conventional venture capital companies, Patentpool Group often takes over the operational management when implementing projects. This approach ensures a clear allocation of tasks, allowing innovators to concentrate exclusively on technical development while the firm's experts handle all business functions. Their services encompass project acquisition, business planning, startup management, financing, intellectual property management, legal and tax consulting, prototype and product development, know-how transfer management, partner search and insertion, distribution of investments and licenses, branding and media design, and marketing and public relations.

Over the years, Patentpool Group has been involved in several notable projects. For instance, they supported SalviCure, a company researching plant-based active ingredients for treating Lyme disease, and Single Atom Technologies, which developed the first functioning single-atom transistor. Additionally, they have been involved with Canify AG, a pharmaceutical company specializing in medical cannabis products. Their unique approach combines financial support with active operational management, aiming for long-term partnerships and sustainable growth in their ventures.